GPCR

31.75

7.08% -2.42

Dopo l'orario di chiusura: 31.65 -0.10 -0.31%

Structure Therapeutics Inc Adr (GPCR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché GPCR Giù? Forum Previsione

Precedente Chiudi:

$34.17

Aprire:

$33.91

Volume 24 ore:

2.08M

Relative Volume:

2.99

Capitalizzazione di mercato:

$1.73B

Reddito:

Utile/perdita netta:

$-100.44M

Rapporto P/E:

-14.78

EPS:

-2.1478

Flusso di cassa netto:

$-105.32M

1 W Prestazione:

-17.96%

1M Prestazione:

-19.62%

6M Prestazione:

-12.17%

1 anno Prestazione:

-40.95%

Intervallo 1D:

$29.48

$33.92

Intervallo di 1 settimana:

$29.48

$38.67

Portata 52W:

$26.61

$66.38

Structure Therapeutics Inc Adr Stock (GPCR) Company Profile

Nome

Structure Therapeutics Inc Adr

Settore

Healthcare (1196)

Industria

Biotechnology (683)

Telefono

(628) 229-9277

Indirizzo

611 GATEWAY BLVD SUITE 223, SOUTH SAN FRANCISCO

Dipendente

136

Cinguettio

Prossima data di guadagno

Ultimi documenti SEC

GPCR's Discussions on Twitter

Confronta GPCR con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
GPCR	31.75	1.73B	0	-100.44M	-105.32M	-2.1478
VRTX	467.01	119.87B	10.63B	-479.80M	-1.35B	13.33
REGN	762.00	83.27B	13.85B	4.65B	3.32B	35.06
ARGX	567.90	33.96B	1.86B	-40.29M	-1.28B	-4.16
ALNY	232.27	30.18B	2.09B	-332.26M	16.06M	-4.14
BNTX	101.87	24.42B	3.30B	-501.07M	1.03B	11.54

Structure Therapeutics Inc Adr Stock (GPCR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-05-21	Iniziato	JP Morgan	Overweight
2024-04-09	Iniziato	Cantor Fitzgerald	Overweight
2023-10-19	Iniziato	JMP Securities	Mkt Outperform
2023-07-27	Iniziato	Piper Sandler	Overweight
2023-05-25	Ripresa	Jefferies	Buy
2023-02-28	Iniziato	BMO Capital Markets	Outperform
2023-02-28	Iniziato	Guggenheim	Buy
2023-02-28	Iniziato	Jefferies	Buy
2023-02-28	Iniziato	SVB Securities	Outperform

Mostra tutto

Structure Therapeutics Inc Adr Borsa (GPCR) Ultime notizie

02:10 AM

FY2024 Earnings Forecast for GPCR Issued By Lifesci Capital - Defense World

02:10 AM

Nov 17, 2024

GPCRStructure Therapeutics Inc. American Depositary Shares Latest Stock News & Market Updates - StockTitan

Nov 17, 2024

Nov 16, 2024

Structure Therapeutics (NASDAQ:GPCR) Trading Down 8.9%Here's What Happened - MarketBeat

Nov 16, 2024

Nov 15, 2024

Structure Therapeutics to Present at Jefferies London Healthcare Conference | GPCR Stock News - StockTitan

Nov 15, 2024

Nov 14, 2024

GSA Capital Partners LLP Purchases Shares of 30,464 Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Nov 14, 2024

Nov 13, 2024

Structure Therapeutics Reports Strong Q3 2024 Results - TipRanks

Nov 13, 2024

Structure Therapeutics Advances Obesity Drug Trial, Reports $915M Cash Position | GPCR Stock News - StockTitan

Nov 13, 2024

Structure Therapeutics Launches Phase 2b Obesity Drug Trial, Expands Testing to Higher Doses | GPCR Stock News - StockTitan

Nov 13, 2024

Nov 05, 2024

Structure Therapeutics Inc. (NASDAQ:GPCR) Shares Bought by Mirae Asset Global Investments Co. Ltd. - Defense World

Nov 05, 2024

Is Viking Therepautics a Buy Now? - MSN

Nov 05, 2024

Oral Proteins and Peptides Market to Reach $28.17 Billion by 2031 As Revealed In New Report - WhaTech

Nov 05, 2024

Some of the Major Key Players in the oral proteins and peptides market are - InsightAce Analytic

Nov 05, 2024

Nov 03, 2024

Structure Therapeutics Inc. (NASDAQ:GPCR) Position Increased by abrdn plc - MarketBeat

Nov 03, 2024

Nov 01, 2024

Ballard Power Systems Inc (NASDAQ: BLDP) Has Great Upside Potential - Stocks Register

Nov 01, 2024

Is Structure Therapeutics Inc ADR (NASDAQ: GPCR) A Good Investment For New Investors Now? - Stocks Register

Nov 01, 2024

Oct 31, 2024

Secretome Therapeutics, Inc. Announces Composition of Matter Patents for Lead Assets STM-01 and STM-21 - Business Wire

Oct 28, 2024

Oct 26, 2024

Brokerages Set Structure Therapeutics Inc. (NASDAQ:GPCR) Target Price at $86.80 - MarketBeat

Oct 26, 2024

Oct 24, 2024

GPCR drugmaker Septerna amasses $288M in IPO - BioPharma Dive

Oct 24, 2024

Oct 17, 2024

Griffin Asset Management Inc. Acquires New Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Oct 17, 2024

Oct 16, 2024